Question

question 2
in part a, you analyzed genes that contribute to two diseases. how can scientists use this information to develop new treatments for these diseases? based on your findings, do you think that scientists will need to develop multiple treatments to control symptoms of these diseases? explain your reasoning.

Explanation:

1. Developing New Treatments: By identifying disease - associated genes, scientists can target the proteins these genes encode. For example, if a gene mutation leads to the overproduction of a harmful protein, they can develop drugs (like small - molecule inhibitors) that block the function of that protein. Also, gene therapy can be explored, where the faulty gene is replaced or edited (using techniques like CRISPR - Cas9) to restore normal function. Another approach is to target the signaling pathways that the gene is involved in. If a gene is part of a pathway that promotes disease progression, drugs can be made to disrupt that pathway.
2. Need for Multiple Treatments: Diseases are often complex. Genes associated with a disease may have different functions in different cell types or at different stages of the disease. Also, there can be genetic variability among patients (different mutations in the same disease - associated gene or different combinations of disease - associated genes). So, one treatment may not be effective for all patients or at all stages of the disease. For example, in cancer, a single targeted therapy may work initially, but the tumor can develop resistance due to genetic changes, so multiple treatments (like a combination of targeted therapy, chemotherapy, and immunotherapy) are needed. In a genetic disease with multiple disease - associated genes, each gene may need to be targeted with a different treatment approach.

Answer:

Scientists can develop new treatments by targeting the proteins encoded by disease - associated genes (e.g., with small - molecule inhibitors), using gene therapy to correct faulty genes, or disrupting disease - promoting signaling pathways. Scientists will likely need multiple treatments. Diseases are complex: disease - associated genes can act differently in various cell types/stages, and patients have genetic variability (mutations/combinations of genes). For example, tumors can develop resistance to single therapies, and genetic diseases with multiple genes need different targeting approaches.